Home > > > Report Detail

Global Orally Disintegrating Films (ODFs) Market Research Report 2023

Publisher Name :
Date: 24-Jan-2023
No. of pages: 101
Inquire Before Buying

Orally disintegrating films can be produced with different polymers, which is the main responsible for properties such as disintegration time and mucoadhesiveness, aiming at controlled and more effective release of the active compounds.

Highlights

The global Orally Disintegrating Films (ODFs) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Orally Disintegrating Films (ODFs) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Orally Disintegrating Films (ODFs) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Orally Disintegrating Films (ODFs) include Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI), IntelGenx, Tapemark, Shilpa Therapeutics, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Films (ODFs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Films (ODFs).

The Orally Disintegrating Films (ODFs) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Orally Disintegrating Films (ODFs) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Orally Disintegrating Films (ODFs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Aquestive Therapeutics

- Kyukyu Pharmaceutical

- BioDelivery(BDSI)

- IntelGenx

- Tapemark

- Shilpa Therapeutics

- CL Pharm

- Lubrizol Life Science

- Adhex Pharma

- DK Livkon

- Arx Pharma

- Aavishkar

- ZIM Laboratories

- Umang Pharmaceuticals

- Cure Pharmaceutical

Segment by Type

- Orodispersible Film

- Oromucosal Film

Segment by Application

- Hospital and Clinic

- Drug Store

- E-commerce

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Orally Disintegrating Films (ODFs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Orally Disintegrating Films (ODFs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Orally Disintegrating Films (ODFs) Market Research Report 2023

Table of Contents
1 Orally Disintegrating Films (ODFs) Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Films (ODFs)
1.2 Orally Disintegrating Films (ODFs) Segment by Type
1.2.1 Global Orally Disintegrating Films (ODFs) Market Value Comparison by Type (2023-2029)
1.2.2 Orodispersible Film
1.2.3 Oromucosal Film
1.3 Orally Disintegrating Films (ODFs) Segment by Application
1.3.1 Global Orally Disintegrating Films (ODFs) Market Value by Application: (2023-2029)
1.3.2 Hospital and Clinic
1.3.3 Drug Store
1.3.4 E-commerce
1.4 Global Orally Disintegrating Films (ODFs) Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Films (ODFs) Revenue 2018-2029
1.4.2 Global Orally Disintegrating Films (ODFs) Sales 2018-2029
1.4.3 Global Orally Disintegrating Films (ODFs) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Orally Disintegrating Films (ODFs) Market Competition by Manufacturers
2.1 Global Orally Disintegrating Films (ODFs) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Orally Disintegrating Films (ODFs) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Orally Disintegrating Films (ODFs) Average Price by Manufacturers (2018-2023)
2.4 Global Orally Disintegrating Films (ODFs) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Orally Disintegrating Films (ODFs), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Films (ODFs), Product Type & Application
2.7 Orally Disintegrating Films (ODFs) Market Competitive Situation and Trends
2.7.1 Orally Disintegrating Films (ODFs) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orally Disintegrating Films (ODFs) Players Market Share by Revenue
2.7.3 Global Orally Disintegrating Films (ODFs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orally Disintegrating Films (ODFs) Retrospective Market Scenario by Region
3.1 Global Orally Disintegrating Films (ODFs) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Orally Disintegrating Films (ODFs) Global Orally Disintegrating Films (ODFs) Sales by Region: 2018-2029
3.2.1 Global Orally Disintegrating Films (ODFs) Sales by Region: 2018-2023
3.2.2 Global Orally Disintegrating Films (ODFs) Sales by Region: 2024-2029
3.3 Global Orally Disintegrating Films (ODFs) Global Orally Disintegrating Films (ODFs) Revenue by Region: 2018-2029
3.3.1 Global Orally Disintegrating Films (ODFs) Revenue by Region: 2018-2023
3.3.2 Global Orally Disintegrating Films (ODFs) Revenue by Region: 2024-2029
3.4 North America Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Films (ODFs) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Orally Disintegrating Films (ODFs) Sales by Country (2018-2029)
3.4.3 North America Orally Disintegrating Films (ODFs) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Films (ODFs) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Orally Disintegrating Films (ODFs) Sales by Country (2018-2029)
3.5.3 Europe Orally Disintegrating Films (ODFs) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
3.6.1 Asia Pacific Orally Disintegrating Films (ODFs) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Orally Disintegrating Films (ODFs) Sales by Country (2018-2029)
3.6.3 Asia Pacific Orally Disintegrating Films (ODFs) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Films (ODFs) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Orally Disintegrating Films (ODFs) Sales by Country (2018-2029)
3.7.3 Latin America Orally Disintegrating Films (ODFs) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Films (ODFs) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Orally Disintegrating Films (ODFs) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Orally Disintegrating Films (ODFs) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Orally Disintegrating Films (ODFs) Sales by Type (2018-2029)
4.1.1 Global Orally Disintegrating Films (ODFs) Sales by Type (2018-2023)
4.1.2 Global Orally Disintegrating Films (ODFs) Sales by Type (2024-2029)
4.1.3 Global Orally Disintegrating Films (ODFs) Sales Market Share by Type (2018-2029)
4.2 Global Orally Disintegrating Films (ODFs) Revenue by Type (2018-2029)
4.2.1 Global Orally Disintegrating Films (ODFs) Revenue by Type (2018-2023)
4.2.2 Global Orally Disintegrating Films (ODFs) Revenue by Type (2024-2029)
4.2.3 Global Orally Disintegrating Films (ODFs) Revenue Market Share by Type (2018-2029)
4.3 Global Orally Disintegrating Films (ODFs) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Orally Disintegrating Films (ODFs) Sales by Application (2018-2029)
5.1.1 Global Orally Disintegrating Films (ODFs) Sales by Application (2018-2023)
5.1.2 Global Orally Disintegrating Films (ODFs) Sales by Application (2024-2029)
5.1.3 Global Orally Disintegrating Films (ODFs) Sales Market Share by Application (2018-2029)
5.2 Global Orally Disintegrating Films (ODFs) Revenue by Application (2018-2029)
5.2.1 Global Orally Disintegrating Films (ODFs) Revenue by Application (2018-2023)
5.2.2 Global Orally Disintegrating Films (ODFs) Revenue by Application (2024-2029)
5.2.3 Global Orally Disintegrating Films (ODFs) Revenue Market Share by Application (2018-2029)
5.3 Global Orally Disintegrating Films (ODFs) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aquestive Therapeutics
6.1.1 Aquestive Therapeutics Corporation Information
6.1.2 Aquestive Therapeutics Description and Business Overview
6.1.3 Aquestive Therapeutics Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aquestive Therapeutics Orally Disintegrating Films (ODFs) Product Portfolio
6.1.5 Aquestive Therapeutics Recent Developments/Updates
6.2 Kyukyu Pharmaceutical
6.2.1 Kyukyu Pharmaceutical Corporation Information
6.2.2 Kyukyu Pharmaceutical Description and Business Overview
6.2.3 Kyukyu Pharmaceutical Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kyukyu Pharmaceutical Orally Disintegrating Films (ODFs) Product Portfolio
6.2.5 Kyukyu Pharmaceutical Recent Developments/Updates
6.3 BioDelivery(BDSI)
6.3.1 BioDelivery(BDSI) Corporation Information
6.3.2 BioDelivery(BDSI) Description and Business Overview
6.3.3 BioDelivery(BDSI) Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BioDelivery(BDSI) Orally Disintegrating Films (ODFs) Product Portfolio
6.3.5 BioDelivery(BDSI) Recent Developments/Updates
6.4 IntelGenx
6.4.1 IntelGenx Corporation Information
6.4.2 IntelGenx Description and Business Overview
6.4.3 IntelGenx Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 IntelGenx Orally Disintegrating Films (ODFs) Product Portfolio
6.4.5 IntelGenx Recent Developments/Updates
6.5 Tapemark
6.5.1 Tapemark Corporation Information
6.5.2 Tapemark Description and Business Overview
6.5.3 Tapemark Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tapemark Orally Disintegrating Films (ODFs) Product Portfolio
6.5.5 Tapemark Recent Developments/Updates
6.6 Shilpa Therapeutics
6.6.1 Shilpa Therapeutics Corporation Information
6.6.2 Shilpa Therapeutics Description and Business Overview
6.6.3 Shilpa Therapeutics Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shilpa Therapeutics Orally Disintegrating Films (ODFs) Product Portfolio
6.6.5 Shilpa Therapeutics Recent Developments/Updates
6.7 CL Pharm
6.6.1 CL Pharm Corporation Information
6.6.2 CL Pharm Description and Business Overview
6.6.3 CL Pharm Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CL Pharm Orally Disintegrating Films (ODFs) Product Portfolio
6.7.5 CL Pharm Recent Developments/Updates
6.8 Lubrizol Life Science
6.8.1 Lubrizol Life Science Corporation Information
6.8.2 Lubrizol Life Science Description and Business Overview
6.8.3 Lubrizol Life Science Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Lubrizol Life Science Orally Disintegrating Films (ODFs) Product Portfolio
6.8.5 Lubrizol Life Science Recent Developments/Updates
6.9 Adhex Pharma
6.9.1 Adhex Pharma Corporation Information
6.9.2 Adhex Pharma Description and Business Overview
6.9.3 Adhex Pharma Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Adhex Pharma Orally Disintegrating Films (ODFs) Product Portfolio
6.9.5 Adhex Pharma Recent Developments/Updates
6.10 DK Livkon
6.10.1 DK Livkon Corporation Information
6.10.2 DK Livkon Description and Business Overview
6.10.3 DK Livkon Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 DK Livkon Orally Disintegrating Films (ODFs) Product Portfolio
6.10.5 DK Livkon Recent Developments/Updates
6.11 Arx Pharma
6.11.1 Arx Pharma Corporation Information
6.11.2 Arx Pharma Orally Disintegrating Films (ODFs) Description and Business Overview
6.11.3 Arx Pharma Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Arx Pharma Orally Disintegrating Films (ODFs) Product Portfolio
6.11.5 Arx Pharma Recent Developments/Updates
6.12 Aavishkar
6.12.1 Aavishkar Corporation Information
6.12.2 Aavishkar Orally Disintegrating Films (ODFs) Description and Business Overview
6.12.3 Aavishkar Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aavishkar Orally Disintegrating Films (ODFs) Product Portfolio
6.12.5 Aavishkar Recent Developments/Updates
6.13 ZIM Laboratories
6.13.1 ZIM Laboratories Corporation Information
6.13.2 ZIM Laboratories Orally Disintegrating Films (ODFs) Description and Business Overview
6.13.3 ZIM Laboratories Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ZIM Laboratories Orally Disintegrating Films (ODFs) Product Portfolio
6.13.5 ZIM Laboratories Recent Developments/Updates
6.14 Umang Pharmaceuticals
6.14.1 Umang Pharmaceuticals Corporation Information
6.14.2 Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Description and Business Overview
6.14.3 Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Product Portfolio
6.14.5 Umang Pharmaceuticals Recent Developments/Updates
6.15 Cure Pharmaceutical
6.15.1 Cure Pharmaceutical Corporation Information
6.15.2 Cure Pharmaceutical Orally Disintegrating Films (ODFs) Description and Business Overview
6.15.3 Cure Pharmaceutical Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cure Pharmaceutical Orally Disintegrating Films (ODFs) Product Portfolio
6.15.5 Cure Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Films (ODFs) Industry Chain Analysis
7.2 Orally Disintegrating Films (ODFs) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Films (ODFs) Production Mode & Process
7.4 Orally Disintegrating Films (ODFs) Sales and Marketing
7.4.1 Orally Disintegrating Films (ODFs) Sales Channels
7.4.2 Orally Disintegrating Films (ODFs) Distributors
7.5 Orally Disintegrating Films (ODFs) Customers
8 Orally Disintegrating Films (ODFs) Market Dynamics
8.1 Orally Disintegrating Films (ODFs) Industry Trends
8.2 Orally Disintegrating Films (ODFs) Market Drivers
8.3 Orally Disintegrating Films (ODFs) Market Challenges
8.4 Orally Disintegrating Films (ODFs) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Orally Disintegrating Films (ODFs) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Orally Disintegrating Films (ODFs) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Orally Disintegrating Films (ODFs) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Orally Disintegrating Films (ODFs) Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Orally Disintegrating Films (ODFs) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Orally Disintegrating Films (ODFs) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Orally Disintegrating Films (ODFs) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Orally Disintegrating Films (ODFs) Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Orally Disintegrating Films (ODFs), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Orally Disintegrating Films (ODFs), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Orally Disintegrating Films (ODFs), Product Type & Application
Table 12. Global Key Manufacturers of Orally Disintegrating Films (ODFs), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orally Disintegrating Films (ODFs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Films (ODFs) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Orally Disintegrating Films (ODFs) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Orally Disintegrating Films (ODFs) Sales by Region (2018-2023) & (K Units)
Table 18. Global Orally Disintegrating Films (ODFs) Sales Market Share by Region (2018-2023)
Table 19. Global Orally Disintegrating Films (ODFs) Sales by Region (2024-2029) & (K Units)
Table 20. Global Orally Disintegrating Films (ODFs) Sales Market Share by Region (2024-2029)
Table 21. Global Orally Disintegrating Films (ODFs) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Orally Disintegrating Films (ODFs) Revenue Market Share by Region (2018-2023)
Table 23. Global Orally Disintegrating Films (ODFs) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Orally Disintegrating Films (ODFs) Revenue Market Share by Region (2024-2029)
Table 25. North America Orally Disintegrating Films (ODFs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Orally Disintegrating Films (ODFs) Sales by Country (2018-2023) & (K Units)
Table 27. North America Orally Disintegrating Films (ODFs) Sales by Country (2024-2029) & (K Units)
Table 28. North America Orally Disintegrating Films (ODFs) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Orally Disintegrating Films (ODFs) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Orally Disintegrating Films (ODFs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Orally Disintegrating Films (ODFs) Sales by Country (2018-2023) & (K Units)
Table 32. Europe Orally Disintegrating Films (ODFs) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Orally Disintegrating Films (ODFs) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Orally Disintegrating Films (ODFs) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Orally Disintegrating Films (ODFs) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Orally Disintegrating Films (ODFs) Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Orally Disintegrating Films (ODFs) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Orally Disintegrating Films (ODFs) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Orally Disintegrating Films (ODFs) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Orally Disintegrating Films (ODFs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Orally Disintegrating Films (ODFs) Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Orally Disintegrating Films (ODFs) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Orally Disintegrating Films (ODFs) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Orally Disintegrating Films (ODFs) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Orally Disintegrating Films (ODFs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Orally Disintegrating Films (ODFs) Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Orally Disintegrating Films (ODFs) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Orally Disintegrating Films (ODFs) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Orally Disintegrating Films (ODFs) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Orally Disintegrating Films (ODFs) Sales (K Units) by Type (2018-2023)
Table 51. Global Orally Disintegrating Films (ODFs) Sales (K Units) by Type (2024-2029)
Table 52. Global Orally Disintegrating Films (ODFs) Sales Market Share by Type (2018-2023)
Table 53. Global Orally Disintegrating Films (ODFs) Sales Market Share by Type (2024-2029)
Table 54. Global Orally Disintegrating Films (ODFs) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Orally Disintegrating Films (ODFs) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Orally Disintegrating Films (ODFs) Revenue Market Share by Type (2018-2023)
Table 57. Global Orally Disintegrating Films (ODFs) Revenue Market Share by Type (2024-2029)
Table 58. Global Orally Disintegrating Films (ODFs) Price (US$/Unit) by Type (2018-2023)
Table 59. Global Orally Disintegrating Films (ODFs) Price (US$/Unit) by Type (2024-2029)
Table 60. Global Orally Disintegrating Films (ODFs) Sales (K Units) by Application (2018-2023)
Table 61. Global Orally Disintegrating Films (ODFs) Sales (K Units) by Application (2024-2029)
Table 62. Global Orally Disintegrating Films (ODFs) Sales Market Share by Application (2018-2023)
Table 63. Global Orally Disintegrating Films (ODFs) Sales Market Share by Application (2024-2029)
Table 64. Global Orally Disintegrating Films (ODFs) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Orally Disintegrating Films (ODFs) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Orally Disintegrating Films (ODFs) Revenue Market Share by Application (2018-2023)
Table 67. Global Orally Disintegrating Films (ODFs) Revenue Market Share by Application (2024-2029)
Table 68. Global Orally Disintegrating Films (ODFs) Price (US$/Unit) by Application (2018-2023)
Table 69. Global Orally Disintegrating Films (ODFs) Price (US$/Unit) by Application (2024-2029)
Table 70. Aquestive Therapeutics Corporation Information
Table 71. Aquestive Therapeutics Description and Business Overview
Table 72. Aquestive Therapeutics Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Aquestive Therapeutics Orally Disintegrating Films (ODFs) Product
Table 74. Aquestive Therapeutics Recent Developments/Updates
Table 75. Kyukyu Pharmaceutical Corporation Information
Table 76. Kyukyu Pharmaceutical Description and Business Overview
Table 77. Kyukyu Pharmaceutical Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Kyukyu Pharmaceutical Orally Disintegrating Films (ODFs) Product
Table 79. Kyukyu Pharmaceutical Recent Developments/Updates
Table 80. BioDelivery(BDSI) Corporation Information
Table 81. BioDelivery(BDSI) Description and Business Overview
Table 82. BioDelivery(BDSI) Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. BioDelivery(BDSI) Orally Disintegrating Films (ODFs) Product
Table 84. BioDelivery(BDSI) Recent Developments/Updates
Table 85. IntelGenx Corporation Information
Table 86. IntelGenx Description and Business Overview
Table 87. IntelGenx Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. IntelGenx Orally Disintegrating Films (ODFs) Product
Table 89. IntelGenx Recent Developments/Updates
Table 90. Tapemark Corporation Information
Table 91. Tapemark Description and Business Overview
Table 92. Tapemark Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Tapemark Orally Disintegrating Films (ODFs) Product
Table 94. Tapemark Recent Developments/Updates
Table 95. Shilpa Therapeutics Corporation Information
Table 96. Shilpa Therapeutics Description and Business Overview
Table 97. Shilpa Therapeutics Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Shilpa Therapeutics Orally Disintegrating Films (ODFs) Product
Table 99. Shilpa Therapeutics Recent Developments/Updates
Table 100. CL Pharm Corporation Information
Table 101. CL Pharm Description and Business Overview
Table 102. CL Pharm Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CL Pharm Orally Disintegrating Films (ODFs) Product
Table 104. CL Pharm Recent Developments/Updates
Table 105. Lubrizol Life Science Corporation Information
Table 106. Lubrizol Life Science Description and Business Overview
Table 107. Lubrizol Life Science Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Lubrizol Life Science Orally Disintegrating Films (ODFs) Product
Table 109. Lubrizol Life Science Recent Developments/Updates
Table 110. Adhex Pharma Corporation Information
Table 111. Adhex Pharma Description and Business Overview
Table 112. Adhex Pharma Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Adhex Pharma Orally Disintegrating Films (ODFs) Product
Table 114. Adhex Pharma Recent Developments/Updates
Table 115. DK Livkon Corporation Information
Table 116. DK Livkon Description and Business Overview
Table 117. DK Livkon Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. DK Livkon Orally Disintegrating Films (ODFs) Product
Table 119. DK Livkon Recent Developments/Updates
Table 120. Arx Pharma Corporation Information
Table 121. Arx Pharma Description and Business Overview
Table 122. Arx Pharma Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Arx Pharma Orally Disintegrating Films (ODFs) Product
Table 124. Arx Pharma Recent Developments/Updates
Table 125. Aavishkar Corporation Information
Table 126. Aavishkar Description and Business Overview
Table 127. Aavishkar Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Aavishkar Orally Disintegrating Films (ODFs) Product
Table 129. Aavishkar Recent Developments/Updates
Table 130. ZIM Laboratories Corporation Information
Table 131. ZIM Laboratories Description and Business Overview
Table 132. ZIM Laboratories Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. ZIM Laboratories Orally Disintegrating Films (ODFs) Product
Table 134. ZIM Laboratories Recent Developments/Updates
Table 135. Umang Pharmaceuticals Corporation Information
Table 136. Umang Pharmaceuticals Description and Business Overview
Table 137. Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Product
Table 139. Umang Pharmaceuticals Recent Developments/Updates
Table 140. Cure Pharmaceutical Corporation Information
Table 141. Cure Pharmaceutical Description and Business Overview
Table 142. Cure Pharmaceutical Orally Disintegrating Films (ODFs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Cure Pharmaceutical Orally Disintegrating Films (ODFs) Product
Table 144. Cure Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Orally Disintegrating Films (ODFs) Distributors List
Table 148. Orally Disintegrating Films (ODFs) Customers List
Table 149. Orally Disintegrating Films (ODFs) Market Trends
Table 150. Orally Disintegrating Films (ODFs) Market Drivers
Table 151. Orally Disintegrating Films (ODFs) Market Challenges
Table 152. Orally Disintegrating Films (ODFs) Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Orally Disintegrating Films (ODFs)
Figure 2. Global Orally Disintegrating Films (ODFs) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Orally Disintegrating Films (ODFs) Market Share by Type in 2022 & 2029
Figure 4. Orodispersible Film Product Picture
Figure 5. Oromucosal Film Product Picture
Figure 6. Global Orally Disintegrating Films (ODFs) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Orally Disintegrating Films (ODFs) Market Share by Application in 2022 & 2029
Figure 8. Hospital and Clinic
Figure 9. Drug Store
Figure 10. E-commerce
Figure 11. Global Orally Disintegrating Films (ODFs) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Orally Disintegrating Films (ODFs) Market Size (2018-2029) & (US$ Million)
Figure 13. Global Orally Disintegrating Films (ODFs) Sales (2018-2029) & (K Units)
Figure 14. Global Orally Disintegrating Films (ODFs) Average Price (US$/Unit) & (2018-2029)
Figure 15. Orally Disintegrating Films (ODFs) Report Years Considered
Figure 16. Orally Disintegrating Films (ODFs) Sales Share by Manufacturers in 2022
Figure 17. Global Orally Disintegrating Films (ODFs) Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Orally Disintegrating Films (ODFs) Players: Market Share by Revenue in 2022
Figure 19. Orally Disintegrating Films (ODFs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Orally Disintegrating Films (ODFs) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Orally Disintegrating Films (ODFs) Sales Market Share by Country (2018-2029)
Figure 22. North America Orally Disintegrating Films (ODFs) Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Orally Disintegrating Films (ODFs) Sales Market Share by Country (2018-2029)
Figure 26. Europe Orally Disintegrating Films (ODFs) Revenue Market Share by Country (2018-2029)
Figure 27. Germany Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Orally Disintegrating Films (ODFs) Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Orally Disintegrating Films (ODFs) Revenue Market Share by Region (2018-2029)
Figure 34. China Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Orally Disintegrating Films (ODFs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Orally Disintegrating Films (ODFs) Sales Market Share by Country (2018-2029)
Figure 45. Lat
  • 2023-2031 Report on Global Rosacea Treatment Market by Player, Region, Type, Application and Sales Channel
    Published: 27-Mar-2023        Price: US 2500 Onwards        Pages: 104
    This report studies the Rosacea Treatment market, covering market size for segment by type (Topical, Oral, etc.), by application (Hospital Pharmacy, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Nestle Skin Health, Teva, Mylan, Bayer, Sun Pharma, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Rosacea Treatment from......
  • 2023-2031 Report on Global Precision Psychiatry Market by Player, Region, Type, Application and Sales Channel
    Published: 27-Mar-2023        Price: US 2500 Onwards        Pages: 100
    This report studies the Precision Psychiatry market, covering market size for segment by type (Sequencing (NGS and Sanger Sequencing) Technology, Polymerase Chain Reaction (RT-PCR and dPCR) Technology, etc.), by application (Hospitals, IDNs, etc.), by sales channel (Direct Channel, Distribution Channel), by player (llumina, Roche, Bio-Rad Laboratories, QIAGEN, Quest Diagnostics, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This......
  • 2023-2031 Report on Global Research Antibodies Market by Player, Region, Type, Application and Sales Channel
    Published: 27-Mar-2023        Price: US 2500 Onwards        Pages: 122
    This report studies the Research Antibodies market, covering market size for segment by type (Monoclonal Antibodies, Polyclonal Antibodies, etc.), by application (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Abcam, Affinity Biologicals, Agilent Technologies, BD, Bethyl Laboratories, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). ......
  • 2023-2031 Report on Global Primary Antibody Market by Player, Region, Type, Application and Sales Channel
    Published: 27-Mar-2023        Price: US 2500 Onwards        Pages: 122
    This report studies the Primary Antibody market, covering market size for segment by type (Monoclonal Antibodies, Polyclonal Antibodies, etc.), by application (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Abcam, Affinity Biologicals, Agilent Technologies, BD, Bethyl Laboratories, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). ......
  • 2023-2031 Report on Global Oral Insulin Market by Player, Region, Type, Application and Sales Channel
    Published: 27-Mar-2023        Price: US 2500 Onwards        Pages: 84
    This report studies the Oral Insulin market, covering market size for segment by type (Type 1 Diabete Insulin, Type 2 Diabete Insulin, etc.), by application (Female, Male, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analys......
  • 2023-2031 Report on Global Rosacea Therapeutics Market by Player, Region, Type, Application and Sales Channel
    Published: 27-Mar-2023        Price: US 2500 Onwards        Pages: 102
    This report studies the Rosacea Therapeutics market, covering market size for segment by type (Topical, Oral, etc.), by application (Hospital Pharmacy, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Nestle Skin Health, Teva, Mylan, Bayer, Sun Pharma, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Rosacea Therapeutic......
  • Global Keyhole Limpet Hemocyanin (Klh) Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 118
    The Keyhole Limpet Hemocyanin (Klh) market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Keyhole Limpet Hemocyanin (Klh) industry, and breaks down according to the type, application, and consumption area of Keyhole Limpet Hemocyanin (Klh). The report also introduces players in the industry from the perspective of the industry ch......
  • Global Recombinant Protein Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 127
    The Recombinant Protein market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Recombinant Protein industry, and breaks down according to the type, application, and consumption area of Recombinant Protein. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Global Chitosan Gel Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 108
    The Chitosan Gel market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Chitosan Gel industry, and breaks down according to the type, application, and consumption area of Chitosan Gel. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading compani......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs